Evaluation of Prostatitis in Autopsied Prostates—Is Chronic Inflammation More Associated With Benign Prostatic Hyperplasia or Cancer?
- 31 May 2008
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 179 (5), 1736-1740
- https://doi.org/10.1016/j.juro.2008.01.034
Abstract
Chronic inflammation (CI) has been associated with prostate cancer and benign prostatic hyperplasia (BPH). However, the prevalence of CI in malignant and benign glands has never been compared. We evaluated the association between inflammation, BPH and cancer in autopsied prostates We analysed prospectively 167 autopsied prostates. Pathological analysis identified each focus of cancer, BPH nodules and areas of acute (AI) or CI. Any cancer focus or BPH nodule involved directly with inflammation was recorded. The association between the prevalence of prostate cancer, BPH, and inflammation was statistically assessed. Inflammation was present in 113 (67.6%) of 167 cases. CI was identified in 88 (53%), AI in 6 (4%) and both CI and AI in 19 (11%) glands. In the majority of cases, inflammation was present in the transitional zone. 93 glands (56%) were involved with BPH and 49 (29%) with cancer. 75% of the glands harboring BPH were also involved with CI, as compared to only 50% of the glands without BPH (p0.1). Among the 27 glands involved with both cancer and BPH, CI was more associated with BPH than cancer (p=0.006). AI was not significantly associated with either BPH or cancer. CI was a common finding in autopsied prostates. It appeared to be directly associated with the presence of BPH, but not with cancer.Keywords
This publication has 21 references indexed in Scilit:
- Needle Biopsies on Autopsy Prostates: Sensitivity of Cancer Detection Based on True PrevalenceJNCI Journal of the National Cancer Institute, 2007
- The Influence of Chronic Inflammation in Prostatic Carcinogenesis: A 5-Year Followup StudyJournal of Urology, 2006
- Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasionThe Prostate, 2006
- Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancerInternational Journal of Cancer, 2003
- Inflammation and cancerNature, 2002
- RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer casesNature Genetics, 2002
- Distribution of Chronic Prostatitis in Radical Prostatectomy Specimens With Up-Regulation of BCL-2 in Areas of InflammationJournal of Urology, 2002
- Consensus development of a histopathological classification system for chronic prostatic inflammationBJU International, 2001
- PHENOTYPIC CHARACTERISATION OF THE DENDRITIC CELL INFILTRATE IN PROSTATE CANCERJournal of Urology, 1998
- Decreased incidence of prostate cancer with selenium supplementation: results of a double‐blind cancer prevention trialBritish Journal of Urology, 1998